These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 7641205

  • 1. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
    Kubo T, Kohno K, Ohga T, Taniguchi K, Kawanami K, Wada M, Kuwano M.
    Cancer Res; 1995 Sep 01; 55(17):3860-4. PubMed ID: 7641205
    [Abstract] [Full Text] [Related]

  • 2. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.
    Takano H, Ise T, Nomoto M, Kato K, Murakami T, Ohmori H, Imamura T, Nagatani G, Okamoto T, Ohta R, Furukawa M, Shibao K, Izumi H, Kuwano M, Kohno K.
    Anticancer Drug Des; 1999 Apr 01; 14(2):87-92. PubMed ID: 10405635
    [Abstract] [Full Text] [Related]

  • 3. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
    Withoff S, Smit EF, Meersma GJ, van den Berg A, Timmer-Bosscha H, Kok K, Postmus PE, Mulder NH, de Vries EG, Buys CH.
    Lab Invest; 1994 Jul 01; 71(1):61-6. PubMed ID: 8041119
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
    Long BH, Wang L, Lorico A, Wang RC, Brattain MG, Casazza AM.
    Cancer Res; 1991 Oct 01; 51(19):5275-83. PubMed ID: 1717144
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines.
    Chen M, Beck WT.
    Oncol Res; 1995 Oct 01; 7(2):103-11. PubMed ID: 7579726
    [Abstract] [Full Text] [Related]

  • 7. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide.
    Asano T, An T, Zwelling LA, Takano H, Fojo AT, Kleinerman ES.
    Oncol Res; 1996 Oct 01; 8(3):101-10. PubMed ID: 8823806
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells.
    Asano T, Kleinerman ES, Zwelling LA, Zhou Z, Fukunaga Y.
    Acta Oncol; 2005 Oct 01; 44(3):240-7. PubMed ID: 16076696
    [Abstract] [Full Text] [Related]

  • 11. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH.
    Cancer Res; 1994 Jan 01; 54(1):152-8. PubMed ID: 7903202
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16.
    Mirski SE, Evans CD, Almquist KC, Slovak ML, Cole SP.
    Cancer Res; 1993 Oct 15; 53(20):4866-73. PubMed ID: 8104687
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of promoter elements involved in the down-regulation of topoisomerase IIalpha expression in a drug-resistant cell line.
    Saxena D, Yiu GK, Ni X, Huang KC, Mantovani R, Jacquemin-Sablon AG, Ng SW.
    Gene; 2004 Nov 10; 342(1):145-55. PubMed ID: 15527974
    [Abstract] [Full Text] [Related]

  • 18. Reduced phosphorylation of topoisomerase II in etoposide-resistant human leukemia K562 cells.
    Ritke MK, Allan WP, Fattman C, Gunduz NN, Yalowich JC.
    Mol Pharmacol; 1994 Jul 10; 46(1):58-66. PubMed ID: 8058057
    [Abstract] [Full Text] [Related]

  • 19. Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell lines.
    Mo YY, Beck WT.
    Oncol Res; 1997 Jul 10; 9(4):193-204. PubMed ID: 9268990
    [Abstract] [Full Text] [Related]

  • 20. Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing.
    Yu Q, Mirski SE, Sparks KE, Cole SP.
    Biochemistry; 1997 May 13; 36(19):5868-77. PubMed ID: 9153428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.